Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice (Q37368611)

20 August 2017

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice (English)

1 reference

20 August 2017

1 reference

S H Zhang

1

1 reference

20 August 2017

R L Reddick

2

1 reference

20 August 2017

E Avdievich

3

1 reference

20 August 2017

L K Surles

4

1 reference

20 August 2017

R G Jones

5

1 reference

20 August 2017

J B Reynolds

6

1 reference

20 August 2017

S H Quarfordt

7

1 reference

20 August 2017

N Maeda

8

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Journal of Clinical Investigation

20 August 2017

1 reference

20 August 2017

99

1 reference

20 August 2017

12

1 reference

20 August 2017

2858-2866

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Probucol inhibits oxidative modification of low density lipoprotein

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Quantitative assessment of atherosclerotic lesions in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

High-density lipoprotein--the clinical implications of recent studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducing gel electrophoresis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

The pathogenesis of atherosclerosis: an overview

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Treatment of homozygous familial hypercholesterolaemia with probucol.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508136

Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis

2 September 2018

1 reference

12 December 2020

The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis

1 reference

12 December 2020

The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins

1 reference

12 December 2020

A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit

1 reference

12 December 2020

Mode of action of probucol in reducing serum cholesterol in mice

1 reference

12 December 2020

Studies on the mechanism of action of probucol

1 reference

12 December 2020

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1 reference

12 December 2020

Discrepancies between the outcome of animal and human studies on the mode of action of probucol

1 reference

12 December 2020

Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels

1 reference

12 December 2020

Influence of probucol on early experimental atherogenesis in hypercholesterolemic rats

1 reference

12 December 2020

The antioxidant butylated hydroxytoluene protects against atherosclerosis

1 reference

12 December 2020

Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaques

1 reference

12 December 2020

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

12 December 2020

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression

1 reference

12 December 2020

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

1 reference

12 December 2020

Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits

1 reference

12 December 2020

Probucol treatment decreases serum concentrations of diet-derived antioxidants

1 reference

12 December 2020

Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI119479

1 reference

20 August 2017

1 reference

20 August 2017

1 reference